1. Pink Sheet

Avastin Use May Be Overly Restricted By Medicare ESA Proposal – Genentech

 
• By Gregory Twachtman

CMS' proposal to place limits on erythropoiesis-stimulating agents in the cancer setting might restrict even proper uses of the cancer drug Avastin (bevacizumab), Genentech says

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from Pink Sheet